APOLLO ENDOSURGERY INC (APEN) Stock Price, Quote, News and Overview
NASDAQ:APEN - Nasdaq - US03767D1081 - Common Stock - Currency: USD
APEN Quote, Performance and Key Statistics
10
+0.08 (+0.81%)
The current stock price of APEN is 10 USD. In the past month the price increased by 0.5%. In the past year, price increased by 65.56%.
APEN Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About APEN
Company Profile
Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. The company is headquartered in West Lake Hills, Texas and currently employs 107 full-time employees. The company went IPO on 2005-04-21. The firm develops and distributes devices that are used by surgeons and gastroenterologists for various procedures related to gastrointestinal conditions including closure of gastrointestinal defects, managing gastrointestinal complications and the treatment of obesity. The firm's products include the OverStitch Endoscopic Suturing System, which enables advanced endoscopic procedures from within the Gastrointestinal tract, or endolumenally, by allowing physicians to suture, especially full-thickness, and secure the approximation of tissue. The X-Tack Endoscopic HeliX Tacking System is a suture-based device designed specifically for closing and healing defects in the lower gastrointestinal tract. The Orbera Intragastric Balloon System is a non-surgical alternative for interventional weight loss.
Company Info
APOLLO ENDOSURGERY INC
1120 S Capital of Texas Hwy Bldg 1 Ste 300
West Lake Hills TEXAS 78746 US
CEO: Todd Newton
Employees: 107
Company Website: http://apolloendo.com
Phone: 15122795100.0
APOLLO ENDOSURGERY INC / APEN FAQ
What is the stock price of APOLLO ENDOSURGERY INC today?
The current stock price of APEN is 10 USD. The price increased by 0.81% in the last trading session.
What is the ticker symbol for APOLLO ENDOSURGERY INC stock?
The exchange symbol of APOLLO ENDOSURGERY INC is APEN and it is listed on the Nasdaq exchange.
On which exchange is APEN stock listed?
APEN stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for APOLLO ENDOSURGERY INC stock?
11 analysts have analysed APEN and the average price target is 10.2 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 10. Check the APOLLO ENDOSURGERY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is APOLLO ENDOSURGERY INC worth?
APOLLO ENDOSURGERY INC (APEN) has a market capitalization of 475.49M USD. This makes APEN a Small Cap stock.
How many employees does APOLLO ENDOSURGERY INC have?
APOLLO ENDOSURGERY INC (APEN) currently has 107 employees.
What are the support and resistance levels for APOLLO ENDOSURGERY INC (APEN) stock?
APOLLO ENDOSURGERY INC (APEN) has a support level at 9.93 and a resistance level at 10.09. Check the full technical report for a detailed analysis of APEN support and resistance levels.
Is APOLLO ENDOSURGERY INC (APEN) expected to grow?
The Revenue of APOLLO ENDOSURGERY INC (APEN) is expected to grow by 18.29% in the next year. Check the estimates tab for more information on the APEN EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy APOLLO ENDOSURGERY INC (APEN) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of APEN, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of APEN, evaluating the profitability, health, valuation and growth aspects
- APOLLO ENDOSURGERY INC (APEN) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- APOLLO ENDOSURGERY INC (APEN) Sales and EPS estimates to see what analysts future expectations are.
- APOLLO ENDOSURGERY INC (APEN) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- APOLLO ENDOSURGERY INC (APEN) Insider and Institutional Ownership to learn about the owners and their transactions.
- APOLLO ENDOSURGERY INC (APEN) Stock Chart to make your own analysis
- APOLLO ENDOSURGERY INC (APEN) Latest news and press-releases to stay up to date.
Does APOLLO ENDOSURGERY INC (APEN) stock pay dividends?
APEN does not pay a dividend.
When does APOLLO ENDOSURGERY INC (APEN) report earnings?
APOLLO ENDOSURGERY INC (APEN) will report earnings on 2023-05-01.
What is the Price/Earnings (PE) ratio of APOLLO ENDOSURGERY INC (APEN)?
APOLLO ENDOSURGERY INC (APEN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.98).
APEN Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to APEN. When comparing the yearly performance of all stocks, APEN is one of the better performing stocks in the market, outperforming 96.28% of all stocks.
APEN Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to APEN. Both the profitability and financial health of APEN have multiple concerns.
APEN Financial Highlights
Over the last trailing twelve months APEN reported a non-GAAP Earnings per Share(EPS) of -0.98. The EPS decreased by -9.99% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 1.04 |
APEN Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 76% to APEN. The Buy consensus is the average rating of analysts ratings from 11 analysts.
For the next year, analysts expect an EPS growth of 13.1% and a revenue growth 18.29% for APEN